Life Sciences & Biotechnology
Title: | Live Attenuated SARS –
CoV-2 vaccine |
Area: | Life Sciences & Biotechnology, COVID-19 Technology |
Focus Area: | Development of vaccine for COVID-19 |
Developing Agency: | Indian Immunologicals Ltd (IIL) - Griffith University, Australia |
Technology Readiness Index: | Commercialized |
| Website Link : | https://indimmune.com/ |
Brief Description
Description : | A Live Attenuated Severe Acute Respiratory Syndrome Coronavirus Is Immunogenic and Efficacious in Golden Syrian Hamsters. The technology looks promising for developing a vaccine for prophylactic, active, single dose immunization against coronavirus in humans, with an enhanced safety profile. The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunization. |
Related Technologies
